Inhibition of PHA and NaI04 mitogenesis by the adenosine deaminase inhibitors erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) and 2-deoxycoformycin (2-dCF)

C T Lum et al. Clin Immunol Immunopathol. 1979 Apr.

. 1979 Apr;12(4):453-9.

doi: 10.1016/0090-1229(79)90050-3.

No abstract available

Similar articles

Comparison of the activity of 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nonyl)adenine in vivo.
Plunkett W, Alexander L, Chubb S, Loo TL. Plunkett W, et al. Biochem Pharmacol. 1979;28(2):201-6. doi: 10.1016/0006-2952(79)90504-5. Biochem Pharmacol. 1979. PMID: 426835 No abstract available.
Synergistic effect of 3'-deoxyadenosine N1-oxide and adenosine deaminase inhibitors on growth of Ehrlich ascites tumor cells in vivo.
Svendsen KR, Overgaard-Hansen K, Frederiksen S. Svendsen KR, et al. Cancer Chemother Pharmacol. 1988;21(1):35-9. doi: 10.1007/BF00262735. Cancer Chemother Pharmacol. 1988. PMID: 3257721
Adenosine and hypoxic vasodilatation.
Dóra E. Dóra E. J Cereb Blood Flow Metab. 1985 Dec;5(4):621-4. doi: 10.1038/jcbfm.1985.96. J Cereb Blood Flow Metab. 1985. PMID: 3877069 No abstract available.
Inhibitors of adenosine deaminase.
Agarwal RP. Agarwal RP. Pharmacol Ther. 1982;17(3):399-429. doi: 10.1016/0163-7258(82)90023-7. Pharmacol Ther. 1982. PMID: 6187032 Review. No abstract available.
Adenosine deaminase inhibitors: their role in chemotherapy and immunosuppression.
Glazer RI. Glazer RI. Cancer Chemother Pharmacol. 1980;4(4):227-35. doi: 10.1007/BF00255266. Cancer Chemother Pharmacol. 1980. PMID: 7002342 Review. No abstract available.

Extracellular guanosine regulates extracellular adenosine levels.
Jackson EK, Cheng D, Jackson TC, Verrier JD, Gillespie DG. Jackson EK, et al. Am J Physiol Cell Physiol. 2013 Mar 1;304(5):C406-21. doi: 10.1152/ajpcell.00212.2012. Epub 2012 Dec 12. Am J Physiol Cell Physiol. 2013. PMID: 23242185 Free PMC article.